DHL Global Forwarding has recently expanded its cold chain capabilities at Kuala Lumpur International Airport, introducing a new 3,500 square meter storage facility that is dual-certified to accommodate products requiring specific temperature ranges. The facility, equipped with DHL Air GxP and IATA CEIV Pharma certifications, aims to bolster support for the Pharmaceutical and Life Science industries in the region. This move is strategic, considering Malaysia’s potential as a regional hub for medical technology companies, with a projected market growth of 8.5% from 2023 to 2028, reaching a market volume of US$4.5 billion by 2028.
The DHL Air GxP certification aligns with the World Health Organisation’s Good Distribution and Storage Practices, ensuring strict adherence to quality and compliance standards essential for pharmaceutical logistics. On the other hand, the IATA CEIV Pharma certification recognizes DHL’s proficiency in handling valuable, time-sensitive pharmaceutical shipments. The new facility boasts cold rooms dedicated to both 15–25°C and 2–8°C storage, offering storage for up to 105 EU pallets and ensuring high-security storage with round-the-clock CCTV surveillance and restricted access.
Advanced Environment Monitoring integrated into the facility provides automated real-time storage temperature monitoring, with data archives for up to a year. Additional features such as the use of R448A refrigerant, food-grade epoxy flooring, airtight doors, and energy-efficient compressors contribute to maintaining optimal storage conditions. Moreover, DHL has assembled a specialized team of Life Sciences Specialists trained and certified in handling such sensitive goods, emphasizing their commitment to ensuring the safe and efficient transport of pharmaceuticals.
DHL Group’s significant investment in Life Sciences infrastructure across the Asia Pacific region, including the expansion of compliant storage facilities in 15 countries, underscores their dedication to enhancing cold chain logistics. With 37 Air GxP-certified stations and 12 IATA CEIV Pharma-certified stations already established in key locations like Kuala Lumpur, Singapore, Tokyo, Seoul, Sydney, and Shanghai, DHL is well-positioned to meet the escalating demands for secure and reliable pharmaceutical logistics in the region.
This development aligns with DHL’s broader vision to lead with best-in-class facilities and expertise, providing customers with top-tier cold chain solutions to meet the evolving needs of the Pharmaceutical and Life Science industries. The meticulous certifications and state-of-the-art features of the new facility in Malaysia exemplify DHL’s commitment to upholding the highest standards of quality, security, and compliance in pharmaceutical logistics. By investing in cutting-edge infrastructure and specialized training for staff, DHL aims to set a new benchmark for cold chain logistics in the Asia Pacific region, ensuring the safe and efficient transport of temperature-sensitive pharmaceuticals.
Key Takeaways:
– DHL’s new cold chain facility in Malaysia, equipped with dual certifications and advanced features, enhances the company’s support for the Pharmaceutical and Life Science industries in the region.
– The facility’s adherence to stringent quality and compliance standards, along with specialized training for staff, reflects DHL’s commitment to ensuring the secure and efficient transport of pharmaceuticals.
– DHL’s significant investment in Life Sciences infrastructure across the Asia Pacific region underscores the company’s dedication to optimizing cold chain logistics and meeting the increasing demand for pharmaceutical transport with top-tier solutions.
Tags: cold chain logistics
Read more on fullyloaded.com.au